This Genomics ETF’s Holdings Wards Off Chinese Competition

Rarely a group lacking for compelling story lines, genomics stocks and exchange traded funds are receiving more attention due to the novel coronavirus epidemic, one that has put the spotlight on the next generation of healthcare.